ESTRELLA IMMUNOPHARMA, INC. Accrued Income Taxes, Current
ESTRELLA IMMUNOPHARMA, INC. (ESLA) had Accrued Income Taxes, Current of $3.69 thousand as of 2023-09-30, per its 10-Q filed 2023-11-20.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current › Taxes Payable, Current
us-gaap:AccruedIncomeTaxesCurrent · last filed 2023-11-20
- 2023-09-30: Accrued Income Taxes, Current $3.69K.
- 2023-06-30: Accrued Income Taxes, Current $4.30K.
- 2023-03-31: Accrued Income Taxes, Current $92.34K.
- 2022-12-31: Accrued Income Taxes, Current $51.18K.
| Period end | Accrued Income Taxes, Current |
|---|---|
| 2023-09-30 | $3.69K 10-Q · filed 2023-11-20 |
| 2023-06-30 | $4.30K 10-Q · filed 2023-11-20 |
| 2023-03-31 | $92.34K 10-Q · filed 2023-05-18 |
| 2022-12-31 | $51.18K 10-Q · filed 2023-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |